Related Experiment Video
Updated: Dec 23, 2025

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
Published on: December 4, 2016
Dentate Nucleus Signal Intensity Increases Following Repeated Gadobenate Dimeglumine Administrations: A Retrospective
Nghi C Nguyen1, Theodore T Molnar1, Lucas G Cummin1
1From the Department of Radiology, University of Pittsburgh, UPMC Presbyterian, 200 Lothrop St, East Wing, 2nd Floor, Suite 200, Pittsburgh, PA 15213-2536 (N.C.N., T.T.M., E.K.); and Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pa (L.G.C.).
Multiple MRI scans using gadobenate dimeglumine showed a dose-dependent increase in signal intensity in the dentate nucleus (DN) and middle cerebral peduncle (MCP). This finding suggests a linear relationship between gadobenate dimeglumine dosage and cerebral signal changes.
Area of Science:
- Radiology
- Neuroimaging
- Medical Imaging
Background:
- Gadolinium-based contrast agents (GBCAs) can increase cerebral signal intensity (SI) on MRI.
- Published data on gadobenate dimeglumine's effects on SI are contradictory.
- Understanding GBCA-related SI changes is crucial for accurate MRI interpretation.
Purpose of the Study:
- To investigate the relationship between gadobenate dimeglumine dosage and SI changes in the brain.
- To evaluate SI alterations in the dentate nucleus (DN) and middle cerebral peduncle (MCP) after multiple administrations of gadobenate dimeglumine.
Main Methods:
- Retrospective study of 43 patients who underwent multiple brain MRIs with gadobenate dimeglumine.
- Analysis of T1-weighted MRI scans at 1.5 T and 3 T.
- Calculation of the DN-to-MCP SI ratio and linear mixed regression analysis.
Main Results:
- A significant linear increase in the DN/MCP SI ratio was observed with increasing gadobenate dimeglumine dosage.
- The mean DN/MCP SI ratio increased by 6.7% in the primary group and 4.0% in the secondary group.
- Each 1 mL of gadobenate dimeglumine correlated with a 0.015% increase in the DN/MCP SI ratio.
Conclusions:
- Multiple administrations of gadobenate dimeglumine lead to a linear increase in DN/MCP SI ratio.
- This finding highlights a dose-dependent effect of gadobenate dimeglumine on cerebral signal intensity.
- Further research may be needed to understand the long-term implications of these SI changes.
More Related Videos
Related Concept Videos
Magnetic Resonance Imaging
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug Accumulation During Multiple Dosing: Repetitive IV Injections

